U.S. markets closed

  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     

  • Dow 30

    31,097.26
    +321.83 (+1.05%)
     

  • Nasdaq

    11,127.84
    +99.11 (+0.90%)
     

  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     

  • Crude Oil

    108.42
    +2.66 (+2.52%)
     

  • Gold

    1,809.70
    +2.40 (+0.13%)
     

  • Silver

    19.82
    -0.54 (-2.64%)
     

  • EUR/USD

    1.0426
    -0.0057 (-0.54%)
     

  • 10-Yr Bond

    2.8890
    -0.0830 (-2.79%)
     

  • GBP/USD

    1.2103
    -0.0072 (-0.59%)
     

  • USD/JPY

    135.1750
    -0.5530 (-0.41%)
     

  • BTC-USD

    19,450.41
    +669.05 (+3.56%)
     

  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     

  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     

  • Nikkei 225

    25,935.62
    -457.42 (-1.73%)
     

Is This Biotech a Safe Stock to Buy?

Alex Carchidi, The Motley Fool
·5 min read
Is This Biotech a Safe Stock to Buy?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • AXSM

Upon first glance, Axsome Therapeutics (NASDAQ: AXSM) doesn't exactly sound like a candidate for being a safe stock that's ready to buy today. At present, the biotech has no approved drugs nor any revenue. Its drug AXS-05 is its flagship program, and it's being investigated in a late-stage clinical trial for its usefulness in treating agitation in Alzheimer's disease, as well as in another trial for smoking cessation.

Continue reading

Recommended Stories